These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 34028789)
1. A case of treatment-resistant pityriasis rubra pilaris responsive to secukinumab. Simpson K; Dolianitis C Australas J Dermatol; 2021 Aug; 62(3):441-442. PubMed ID: 34028789 [No Abstract] [Full Text] [Related]
2. Rapid response of pityriasis rubra pilaris with psoriasis overlap to secukinumab. Cole D; Mohammad T; Lim H Br J Dermatol; 2019 Dec; 181(6):1331-1332. PubMed ID: 31260082 [No Abstract] [Full Text] [Related]
3. Pityriasis rubra pilaris with polyarthritis treated with adalimumab. Chiu HY; Tsai TF J Am Acad Dermatol; 2013 Jan; 68(1):187-8. PubMed ID: 23244382 [No Abstract] [Full Text] [Related]
4. Rapid response of erythrodermic pityriasis rubra pilaris to tildrakizumab. Villa-Gonzalez JM; Gonzalez-Hermosa MR; Atxutegi-Ayesta X; Ratón Nieto JA; Gardeazabal García J; Lasa Elgezua O Clin Exp Dermatol; 2024 Jan; 49(2):177-180. PubMed ID: 37847660 [No Abstract] [Full Text] [Related]
5. Secukinumab is an effective and safe treatment for refractory pityriasis rubra pilaris. Papini M; Russo A; Natalini Y; Troiani L; Cassiani L Ital J Dermatol Venerol; 2021 Aug; 156(4):501-502. PubMed ID: 33179881 [No Abstract] [Full Text] [Related]
6. Successful treatment of Pityriasis rubra pilaris with brodalumab. De Rosa A; Gambardella A; Licata G; Alfano R; Argenziano G Australas J Dermatol; 2020 May; 61(2):e249-e251. PubMed ID: 31851372 [No Abstract] [Full Text] [Related]
7. Refractory Type I pityriasis rubra pilaris treated with tildrakizumab. Licata G; Gambardella A; Calabrese G; Pagliuca F; Alfano R; Argenziano G Clin Exp Dermatol; 2021 Dec; 46(8):1594-1595. PubMed ID: 34101231 [No Abstract] [Full Text] [Related]
8. Treatment of Pityriasis Rubra Pilaris With Guselkumab. Pilz AC; Seiringer P; Biedermann T; Eyerich K JAMA Dermatol; 2019 Dec; 155(12):1424-1426. PubMed ID: 31577328 [No Abstract] [Full Text] [Related]
9. Successful treatment of severe pityriasis rubra pilaris with secukinumab in a 3-year-old boy. Xu YH; Dong DD; Lin YF; Wang Q; Huang LM; Shi JQ Clin Exp Dermatol; 2022 Nov; 47(11):2043-2045. PubMed ID: 35906074 [TBL] [Abstract][Full Text] [Related]
14. Secukinumab monotherapy successfully treated severe refractory type V (atypical juvenile) pityriasis rubra pilaris: A case report and literature review. Liang JY; Ye RX; Tian X; Zhang SQ; Zhang XB Dermatol Ther; 2020 Nov; 33(6):e14097. PubMed ID: 32725719 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment of pityriasis rubra pilaris with adalimumab - case report. Bravo EA; Carrion L; Paucar SM; Mendoza R; Rivera C Dermatol Online J; 2014 Apr; 20(4):22374. PubMed ID: 24746310 [TBL] [Abstract][Full Text] [Related]
16. Adalimumab for the treatment of pityriasis rubra pilaris: a case report. Wassef C; Lombardi A; Rao BK Cutis; 2012 Nov; 90(5):244-7. PubMed ID: 23270195 [TBL] [Abstract][Full Text] [Related]